BioSpace News Archive

DarioHealth Corp., a pioneer in the global digital therapeutics market, announced that Omar Manejwala, M.D., Chief Medical Officer, will present at the virtual Going Digital: Behavioral Tech Summit.

Emmes announced that it was selected as one of the best places to work in the greater Washington area.

Fluidigm Corporation, an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced a collaboration with Bethyl Laboratories to provide broader verified antibody access for researchers using Fluidigm’s Imaging Mass Cytometry™ technology.

Ascletis Pharma Inc. announces that its partner Sagimet Biosciences Inc, announced positive results on oral, once-daily non-alcoholic steatohepatitis drug candidate TVB-2640 from its Phase 2 clinical trial.

Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that Reenie McCarthy , CEO, will participate in a fireside chat at the virtual BMO Capital Markets 2020 Prescripti

YUMAB GmbH previously announced it identified fully human monoclonal antibodies with neutralizing activity against live coronavirus strain SARS-CoV-2. The company deployed its advanced antibody discovery platform to r

Atara Biotherapeutics Announces First Patient Enrolled in Randomized Placebo-Controlled Study of Allogeneic T-cell Therapy ATA188 in Progressive Forms of Multiple Sclerosis Based on promising results from the Phase 1a study including sustained disability improvements among progressive MS patients, the Phase 1b study will assess clinical outcomes including measures of disability, physical and cognitive function, biomarkers and MRI imaging as well as safety

GSK, Johns Hopkins Medical Institutions, Mass General Cancer Center join global network to accelerate discoveries in COVID-19, oncology, immuno-oncology and neurology

CohBar, Inc., a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced the publication of “AGE LATER: Health Span, Life Span, and the New Science of Longevity,” authored by CohBar founder Nir Barzilai, M.D.

Kangpu Biopharmaceuticals, a clinical-stage company focused on the discovery and development of next-generation of immunomodulatory small molecules for the treatments of solid tumors, hematological malignancies, auto-immune diseases as well as inflammatory disorders, today announced that two posters highlighting preclinical data of the comp